NCT05837754View on ClinicalTrials.gov

A Study to Assess the Gut Health Effects of Oil Compound on Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

March 20, 2024

Study Completion Date

March 20, 2024

Conditions
Gut Health
Interventions
OTHER

C8-C12

5-15mL (one teaspoon to one tablespoon) once or twice a day. The participants will be dispensed a 5 ml pipette for consuming the IP.

OTHER

Placebo

5-15mL (one teaspoon to one tablespoon) once or twice a day. The participants will be dispensed a 5 ml pipette for consuming the IP.

Trial Locations (7)

302039

Maharaja Agrasen Superspeciality Hospital, Jaipur

380013

Apex Hospital, Ahmedabad

390021

Aman Hospital and Research Centre, Vadodara

400067

Shantaee Nursing Home, Mumbai

400080

Hira Mongi Navneet Hospital, Mulund East

411027

Sangvi Multispeciality Hospital, Pune

411057

Lifepoint Multispeciality Hospital, Pune

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT05837754 - A Study to Assess the Gut Health Effects of Oil Compound on Healthy Adults | Biotech Hunter | Biotech Hunter